caa a22 4500 465785573 CHVBK 20180323112008.0 cr unu---uuuuu 170327e19901201xx s 000 0 eng 10.1007/BF01280249 doi (NATIONALLICENCE)springer-10.1007/BF01280249 Comparison of technetium 99m-phytate and technetium 99m-sulphur colloid in primary bone tumours [Elektronische Daten] [P. Rao, Sumathi Murthy, S. Muddukrishna, Siddalinga Devaru, E. Radhakrishnan, M. Bhargava] Eleven patients with proven primary bone tumour (five Ewing sarcomas, six osteosarcomas) and two cases of metastatic bone involvement (primary other than bone) were investigated with99mTc-phytate and99mTc-sulphur colloid to compare the behaviour of the two radiopharmaceuticals at the tumour site. After intravenous administration of the respective radiopharmaceutical, imaging of the tumour site and its contralateral part was carried out at 15 min and 1 h intervals. The data were stored in our computer. Bone scanning was also carried out in all patients.99mTc-phytate uptake was observed at the tumour site in ten cases. The99mTc-sulphur colloid study revealed sparse or no significant uptake in eight cases. In two patients, with osteosarcoma99mTc-sulphur colloid investigation showed uptake at the primary tumour site. However, the distribution pattern is different from that of99mTc-phytate. No significant uptake of either 99mTc-phytate or99mTc-sulphur colloid was observed in the two patients with metastatic skeletal disease. It may be concluded that the unusual accumulation of99mTc-phytate at the tumour site is not due to any generalized reticuloendothelial phenomenon and that the radiopharmaceutical itself is responsible for this. Springer-Verlag, 1990 Technetium 99m-phytate nationallicence Ewing sarcoma nationallicence Osteosarcoma nationallicence Technetium 99m-sulphur colloid nationallicence Rao P. Department of Nuclear Medicine, Kidwai Memorial Institute of Oncology, 560029, Bangalore, India aut Murthy Sumathi Department of Nuclear Medicine, Kidwai Memorial Institute of Oncology, 560029, Bangalore, India aut Muddukrishna S. Radiopharmaceuticals Division, Bhabha Atomic Research Centre, Trombay, Bombay, India aut Devaru Siddalinga Department of Nuclear Medicine, Kidwai Memorial Institute of Oncology, 560029, Bangalore, India aut Radhakrishnan E. Department of Nuclear Medicine, Kidwai Memorial Institute of Oncology, 560029, Bangalore, India aut Bhargava M. Department of Pathology, Kidwai Memorial Institute of Oncology, 560029, Bangalore, India aut European Journal of Nuclear Medicine Springer-Verlag 16/12(1990-12-01), 847-853 0340-6997 16:12<847 1990 16 259 https://doi.org/10.1007/BF01280249 text/html Onlinezugriff via DOI 1 research-article jats NATIONALLICENCE 856 40 https://doi.org/10.1007/BF01280249 text/html Onlinezugriff via DOI NATIONALLICENCE 700 1- Rao P. Department of Nuclear Medicine, Kidwai Memorial Institute of Oncology, 560029, Bangalore, India aut NATIONALLICENCE 700 1- Murthy Sumathi Department of Nuclear Medicine, Kidwai Memorial Institute of Oncology, 560029, Bangalore, India aut NATIONALLICENCE 700 1- Muddukrishna S. Radiopharmaceuticals Division, Bhabha Atomic Research Centre, Trombay, Bombay, India aut NATIONALLICENCE 700 1- Devaru Siddalinga Department of Nuclear Medicine, Kidwai Memorial Institute of Oncology, 560029, Bangalore, India aut NATIONALLICENCE 700 1- Radhakrishnan E. Department of Nuclear Medicine, Kidwai Memorial Institute of Oncology, 560029, Bangalore, India aut NATIONALLICENCE 700 1- Bhargava M. Department of Pathology, Kidwai Memorial Institute of Oncology, 560029, Bangalore, India aut NATIONALLICENCE 773 0- European Journal of Nuclear Medicine Springer-Verlag 16/12(1990-12-01), 847-853 0340-6997 16:12<847 1990 16 259 Metadata rights reserved Springer special CC-BY-NC licence nationallicence BK010053 XK010053 XK010000 NATIONALLICENCE NATIONALLICENCE NL-springer